These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7840591

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.
    Chen HY, Bonfiglio G, Allen M, Piper D, Edwardson T, McVey D, Livermore DM.
    J Antimicrob Chemother; 1993 Aug; 32(2):247-66. PubMed ID: 8226427
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.
    Gu JW, Fang W, Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1992 Aug; 15(7):613-20. PubMed ID: 1330421
    [Abstract] [Full Text] [Related]

  • 24. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
    Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR.
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
    [Abstract] [Full Text] [Related]

  • 29. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Hecht DW, Osmolski JR.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
    [Abstract] [Full Text] [Related]

  • 30. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS, Hastings RW.
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [Abstract] [Full Text] [Related]

  • 31. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
    Schaumann R, Funke M, Janssen E, Rodloff AC.
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3413-6. PubMed ID: 22430962
    [Abstract] [Full Text] [Related]

  • 32. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 33. [Activity of trovafloxacin and ten other antimicrobials against gram negative anaerobic bacilli].
    Chávez M, García López JL, Coronilla J, Bernal S, Valverde A, Martín Mazuelos E.
    Rev Esp Quimioter; 1998 Dec; 11(4):349-52. PubMed ID: 9990149
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of the new fluoroquinolone CP-99,219.
    Neu HC, Chin NX.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2615-22. PubMed ID: 7872757
    [Abstract] [Full Text] [Related]

  • 35. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL, Fuchs PC.
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.
    Ednie LM, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2459-62. PubMed ID: 9736586
    [Abstract] [Full Text] [Related]

  • 38. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group.
    Murray PR, Cantrell HF, Lankford RB.
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):111-20. PubMed ID: 7805355
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.